Cardiol Therapeutics (CRDL) Inventory (2020 - 2021)
Cardiol Therapeutics (CRDL) reported Inventory of $14273.9 for Q3 2021, down 89.04% on a YoY basis from $130272.8 in Q3 2020, and down 2.35% quarter-over-quarter from $14617.5 in Q2 2021.
Cardiol Therapeutics (CRDL) Inventory (2020 - 2021) Analysis & Trends
Cardiol Therapeutics has reported Inventory for 2 years, with the latest figure at $14273.9 in Q3 2021.
- For the quarter ending Q3 2021, Inventory fell 89.04% year-over-year to $14273.9; the trailing twelve-month figure through Sep 2021 stood at $14273.9 (down 89.04% YoY), and the FY2020 full-year result was $13782.4, changed N/A from the prior year.
- Inventory for Q3 2021 stood at $14273.9, down from $14617.5 in the prior quarter.
- The five-year high for Inventory was $130272.8 in Q3 2020, with the low at $13782.4 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.55 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 178.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 131.84 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 64.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.72 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 336.70 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 61.34 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 79.07 Mn |
| 10 | Cardiol Therapeutics | 169.92 Mn | 149.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 14,273.95 |
| Jun 30, 2021 | 14,617.46 |
| Dec 31, 2020 | 13,782.44 |
| Sep 30, 2020 | 130,272.80 |